Loading…
Loading…
EQUITY / NYSE · XASE
cbdMD Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.4295 USD
Observed: 10/05/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/05/2026 · 0.4295 USD · Volume 81,439
20 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 3 | 2025 / Quarter 3 | Change |
|---|---|---|---|
| Revenue | 5,553,738 USD | 4,606,796 USD | +20.56% |
| Operating profit | -1,130,477 USD | -904,686 USD | — |
| Net income | -1,127,202 USD | -895,272 USD | — |
| Cash and cash equivalents | 2,118,339 USD | — | — |
| Total liabilities | 4,933,563 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 304/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 310/01/2025 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 210/01/2025 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 110/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 309/30/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Year end10/01/2024 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 304/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 2,118,339 USD | — | 2,638,243 USD | — | 3,387,933 USD | 2,261,242 USD | 2,261,242 USD | — |
| Gross profitIncome statement | 3,037,534 USD | 9,295,746 USD | 3,256,922 USD | 6,258,213 USD | 3,001,294 USD | — | 11,968,255 USD | 2,831,087 USD |
| Net incomeIncome statement | -1,127,202 USD | -2,208,315 USD | -797,978 USD | -1,081,111 USD | -283,131 USD | — | -2,040,902 USD | -895,272 USD |
| Operating profitIncome statement | -1,130,477 USD | -2,217,553 USD | -800,784 USD | -1,087,074 USD | -286,288 USD | — | -2,162,590 USD | -904,686 USD |
| RevenueIncome statement | 5,553,738 USD | 16,210,701 USD | 5,640,059 USD | 10,656,964 USD | 5,016,904 USD | — | 19,190,468 USD | 4,606,796 USD |
| Total assetsBalance sheet | 13,145,833 USD | — | 12,252,849 USD | — | 11,782,124 USD | 10,419,950 USD | 10,419,950 USD | — |
| Total equityBalance sheet | 8,212,270 USD | — | 9,284,749 USD | — | 9,007,966 USD | 7,226,107 USD | 7,226,107 USD | 6,110,503 USD |
| Total liabilitiesBalance sheet | 4,933,563 USD | — | 2,968,100 USD | — | 2,774,158 USD | 3,193,843 USD | 3,193,843 USD | — |
| Capital expendituresCash flow statement | — | 188,615 USD | — | 170,550 USD | 164,802 USD | — | 184,172 USD | — |
| Financing cash flowCash flow statement | — | 1,966,407 USD | — | 2,026,088 USD | 2,103,957 USD | — | 1,445,236 USD | — |
| Investing cash flowCash flow statement | — | -132,188 USD | — | -114,123 USD | -164,802 USD | — | -184,172 USD | — |
| Operating cash flowCash flow statement | — | -1,977,122 USD | — | -1,534,964 USD | -812,464 USD | — | -1,452,375 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 05/14/2026 | Open report ↗ Published: 05/14/2026 | Open report ↗ Published: 02/17/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 12/19/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.